This article has multiple issues. Please help improve it or discuss these issues on the talk page . (Learn how and when to remove these messages)
|
Harvinder Sahota | |
---|---|
Born | Iqbal 15 April 1941 |
Other names | H Sahota, Harry Sahota, Harvy Sahota |
Alma mater | University of Punjab M.B.B.S. (1965) University of Liverpool (1970) Cardiff University (1971) University of Rochester (1976) |
Occupation(s) | Cardiologist, Surgeon |
Years active | 1976-present |
Known for | Perfusion Balloon Angioplasty |
Board member of | Orange County Emergency Medicine Commission Metro Hospital Heart Institute Institute of Therapy, Tbilisi Claremont Lincoln University |
Harvinder Sahota (born 15 April 1941) is an Indian American cardiologist. [1] [2] He is the inventor of the FDA-approved Perfusion Balloon Angioplasty known as "Sahota Perfusion Balloon". [3] [4]
Sahota holds two dozen patents for other medical inventions including Red Laser Light for prevention of Restenosis, Multi-Lobe Balloon, Fibrin coated Stent, Hemostat to stop bleeding from ruptured artery during the procedure. [5] [6] He holds license to promote a drug-coated stent. He performed the first coronary Angioplasty in many hospitals around the world including India, Mexico, Russia, Ukraine and the United States.[ citation needed ] [7] He has served as the Vice Chairman and Chairman of Orange County Emergency Medicine Commission in California and Research Director and Advisory Board members of the Metro Hospital Heart Institute in New Delhi, India, and Tbilisi, Republic of Georgia. [3] Currently, he serves on the Board of Directors of Claremont Lincoln University. [8]
Sahota was born on 15 April 1941 to Lachman Singh and Dhan Kaur in Basti Tankawali, near Ferozepur in the state of Punjab, India. [5] He was named Iqbal. [5] Later at the age of five, his name was changed to Harvinder as a result of medical setback he suffered in which he was declared dead. [9] Because he was revived by a physician, the event was considered a second birth requiring a new name. [5]
Sahota attended high schools and colleges in India, majoring in medicine. After completing an M.B.B.S. from the University of Punjab in 1965, Harvinder did Internship in Punjab Medical College. In 1967, he went to England to do further residency and specialization in medicine. For further specialization he enrolled as a post graduate student at the University of Liverpool where he did his specialization in tropical medicine and pulmonary in Cardiff and London Hammersmith Hospitals.[ citation needed ]
Sahota came to the United States in 1974. He did his fellowship in cardiology at the University of Rochester in New York. Then he went to Regina, Saskatchewan, Canada to complete his chief residency. In 1977, he came to St Vincent's hospital in Los Angeles, California to do another fellowship in cardiology. After completing his second fellowship in cardiology at St. Vincent, he started his practice in cardiology in Los Angeles in 1978.[ citation needed ]
In 1985, Sahota invented "Sahota Perfusion Balloon" which allows blood to flow to the heart muscle during inflation and prevents chest pain during the operation. After getting the US FDA approval in the 1980s the balloon is now used in angioplasty surgeries all over the world. [10] Sahota went on to invent several others devices, some non-medical, including the one with his son Neil about Identity Theft, especially for credit cards. [5] On 17 January 1990 Sahota performed the first coronary angioplasty in North India and nine more followed in the week that the team spent in Chandigarh. [1] [8]
After the perfusion balloon, Sahota invented Multi-lobe perfusion balloon that straightens the artery on inflation during operation preventing blockages to occur at the bend of the artery. As an inventor, he holds a total of 24 patents and many other medical inventions such as Red Laser Light for prevention of Restenosis, Fibrin coated Stent, Hemostat to stop bleeding from ruptured artery during the procedure.[ citation needed ]
In 2000, Sahota received the distinguished physician award presented by former Indian Prime Minister I. K. Gujral and was honored by the National Federation of Indian-American Associations in the United States. [3] In 2003, he was appointed commissioner of medicine for Orange County, California, by the Orange County board of supervisors.[ citation needed ]
In 2012, Sahota was honored by the American Heart Association for his cardiovascular science and medicine research and his significant contribution to interventional cardiology. [4] [11] In the same year, he was also awarded the Golden Orange Award by the World Affairs Council of Orange County. [12]
Angioplasty, also known as balloon angioplasty and percutaneous transluminal angioplasty (PTA), is a minimally invasive endovascular procedure used to widen narrowed or obstructed arteries or veins, typically to treat arterial atherosclerosis.
A coronary catheterization is a minimally invasive procedure to access the coronary circulation and blood filled chambers of the heart using a catheter. It is performed for both diagnostic and interventional (treatment) purposes.
Restenosis is the recurrence of stenosis, a narrowing of a blood vessel, leading to restricted blood flow. Restenosis usually pertains to an artery or other large blood vessel that has become narrowed, received treatment to clear the blockage, and subsequently become re-narrowed. This is usually restenosis of an artery, or other blood vessel, or possibly a vessel within an organ.
Interventional cardiology is a branch of cardiology that deals specifically with the catheter based treatment of structural heart diseases. Andreas Gruentzig is considered the father of interventional cardiology after the development of angioplasty by interventional radiologist Charles Dotter.
Andreas Roland Grüntzig was a German radiologist and cardiologist, with foundational interest, training and research in epidemiology and angiology. He is known for being the first to develop successful balloon angioplasty for expanding lumens of narrowed arteries. He was born in Dresden.
Percutaneous coronary intervention (PCI) is a minimally invasive non-surgical procedure used to treat narrowing of the coronary arteries of the heart found in coronary artery disease. The procedure is used to place and deploy coronary stents, a permanent wire-meshed tube, to open narrowed coronary arteries. PCI is considered 'non-surgical' as it uses a small hole in a peripheral artery (leg/arm) to gain access to the arterial system, an equivalent surgical procedure would involve the opening of the chest wall to gain access to the heart area. The term 'coronary angioplasty with stent' is synonymous with PCI. The procedure visualises the blood vessels via fluoroscopic imaging and contrast dyes. PCI is performed by an interventional cardiologists in a catheterization laboratory setting.
Firozpur district, also known as Ferozepur district, is one of the twenty-three districts in the state of Punjab, India. Firozpur district comprises an area of 2,190 km2 (850 sq mi).
A drug-eluting stent (DES) is a tube made of a mesh-like material used to treat narrowed arteries in medical procedures both mechanically and pharmacologically. A DES is inserted into a narrowed artery using a delivery catheter usually inserted through a larger artery in the groin or wrist. The stent assembly has the DES mechanism attached towards the front of the stent, and usually is composed of the collapsed stent over a collapsed polymeric balloon mechanism, the balloon mechanism is inflated and used to expand the meshed stent once in position. The stent expands, embedding into the occluded artery wall, keeping the artery open, thereby improving blood flow. The mesh design allows for stent expansion and also for new healthy vessel endothelial cells to grow through and around it, securing it in place.
The history of invasive and interventional cardiology is complex, with multiple groups working independently on similar technologies. Invasive and interventional cardiology is currently closely associated with cardiologists, though the development and most of its early research and procedures were performed by diagnostic and interventional radiologists.
A coronary stent is a tube-shaped device placed in the coronary arteries that supply blood to the heart, to keep the arteries open in patients suffering from coronary heart disease. The vast majority of stents used in modern interventional cardiology are drug-eluting stents (DES). They are used in a medical procedure called percutaneous coronary intervention (PCI). Coronary stents are divided into two broad types: drug-eluting and bare metal stents. As of 2023, drug-eluting stents were used in more than 90% of all PCI procedures. Stents reduce angina and have been shown to improve survival and decrease adverse events after a patient has suffered a heart attack—medically termed an acute myocardial infarction.
Pulmonary artery stenosis (PAS) is a narrowing of the pulmonary artery. The pulmonary artery is a blood vessel moving blood from the right side of the heart to the lungs. This narrowing can be due to many causes, including infection during pregnancy, a congenital heart defect, a problem with blood clotting in childhood or early adulthood, or a genetic change.
Julio Palmaz is a doctor of vascular radiology at University of Texas Health Science Center at San Antonio. He studied at the National University of La Plata in Argentina, earning his medical degree in 1971. He then practiced vascular radiology at the San Martin University Hospital in La Plata before moving to the University of Texas Health and Science Center at San Antonio. He is known for inventing the balloon-expandable stent, for which he received a patent filed in 1985. It was recognized in Intellectual Property International Magazine as one of "Ten Patents that Changed the World" in the last century. His early stent research artifacts are now part of the medical collection of the Smithsonian Institution in Washington, DC. He continues to innovate on his initial designs, developing new endovascular devices.
Dr Purshotam Lal is an Indian Interventional cardiologist who has to his credit the pioneering of over 20 interventional cardiology procedures for the first time in India, some of which were the first time in the World. Trained in UK, US and Germany, and he has held various faculty positions including Professor, Advisor, etc.
Ulrich Sigwart is a German retired cardiologist known for his pioneering role in the conception and clinical use of stents to keep blood vessels open, and introducing a non-surgical intervention, alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy.
Mathew Samuel Kalarickal is an Indian cardiologist widely known as the father of angioplasty in India. He specializes in coronary angioplasty, carotid stenting, coronary stenting and rotablator atherectomy.
Ashok Seth is an Indian interventional cardiologist, credited with the performance of over 50,000 angiograms and 20,000 angioplasties, which has been included in the Limca Book of Records, a book for achievements and records from an Indian perspective. He is a Fellow of the Royal Colleges of Physicians of London, Edinburgh and Ireland and serves as the chief cardiologist, holding the chairs of the department of cardiovascular sciences and cardiology council at the Fortis Healthcare. Seth, a recipient of the Order of Isabella the Catholic, was honored by the Government of India with the fourth highest Indian civilian award of Padma Shri, in 2003, followed by Padma Bhushan, the third highest Indian civilian award, in 2015.
Nagarur Gopinath was an Indian surgeon and one of the pioneers of cardiothoracic surgery in India. He is credited with the first successful performance of open heart surgery in India which he performed in 1962. He served as the honorary surgeon to two Presidents of India and was a recipient of the fourth highest Indian civilian award of Padma Shri in 1974 and Dr. B. C. Roy Award, the highest Indian medical award in 1978 from the Government of India.
Daljeet Singh Gambhir is an Indian cardiologist, medical academic, researcher and inventor and the Group Director of Cardiology at Kailash Group of Hospitals and Heart Institute, Noida. He is the inventor of Infinnium Paclitaxel-Eluting Stent, a reportedly cheaper drug-eluting stent which he first presented at the EuroPCR meeting held in Paris in 2003. A fellow of the National Academy of Medical Sciences and an honorary fellow of the Indian College of Cardiology, he is reported to have performed over 10,000 coronary interventions. The Government of India awarded him the fourth highest civilian honour of the Padma Shri, in 2016, for his contributions to medicine.
Donald S. Baim was a researcher and clinician in the field of interventional cardiology. Baim's primary research focused on coronary blood flow, catheter intervention in heart disease, and congestive heart failure. His work helped to shift the use of catheters from a purely diagnostic tool to a therapeutic tool. After receiving a medical degree from Yale and initial medical training, residency and a fellowship at Stanford University Medical Center, Baim spent the bulk of his career at Beth Israel Hospital and at the Brigham and Women's Hospital in Boston. In 1993, Baim founded the Beth Israel Hospital's Cardiovascular Data Analysis Center (CDAC) -- later to be named Harvard Clinical Research Institute (HCRI). Baim died of cancer in November 2009. In October 2016, HCRI changed its name to the Baim Institute for Clinical Research.
Alfredo E. Rodríguez is an Argentine interventional cardiologist, clinical researcher, and author. He is the Chief of Interventional Cardiology Service at Otamendi Hospital and Director and Founder of the Cardiovascular Research Center (CECI) a non -profit Research Organization in Buenos Aires Argentina.